Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
Completed · Phase 1
Conditions studied: Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer
In brief
This study is being conducted to assess the safety and tolerability of relugolix with other agents approved for use in combination with androgen deprivation therapy (ADT) for a 12-week treatment period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate cancer (mCSPC) or non-metastatic or metastatic castration-resistant prostate cancer (nmCRPC or mCRPC).
Key facts
- Study ID
- NCT04666129
- Run by
- Sumitomo Pharma America, Inc.
- People needed
- 48
- Starts
- 2021-02-18
- Expected to finish
- 2024-05-28
- Last updated by the study team
- 2025-08-17
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Urological Associates of Southern Arizona, P.C. — Tucson, Arizona, United States
- Arkansas Urology — Little Rock, Arkansas, United States
- Colorodo Clinical Research — Lakewood, Colorado, United States
- Chesapeake Urology Research Associates — Baltimore, Maryland, United States
- University of Massachusetts Medical School — Worcester, Massachusetts, United States
- New Jersey Urology — Saddle Brook, New Jersey, United States
- Clinical Research Alliance, Inc. — Westbury, New York, United States
- Alliance Urology — Greensboro, North Carolina, United States
- Wake Forest Baptist Health — Winston-Salem, North Carolina, United States
- Helios Clinical Research, LLC. — Middleburg Heights, Ohio, United States
- Center for Advanced Urology, LLP d/b/a: MidLantic Urology — Bala-Cynwyd, Pennsylvania, United States
- Keystone Urology Specialists — Lancaster, Pennsylvania, United States
- Carolina Urologic Research Center — Myrtle Beach, South Carolina, United States
- Urology Associates, P.C. — Nashville, Tennessee, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
- Urology San Antonio — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.